HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibitory effect of N-palmitoylphosphatidylethanolamine on macrophage phagocytosis through inhibition of Rac1 and Cdc42.

Abstract
The production of N-acylethanolamine (NAE) is enhanced during inflammation. NAE is synthesized from phosphatidylethanolamine with N-acylphosphatidylethanolamine (NAPE) as a precursor. The amount of NAPE at the site of inflammation exceeds that of NAE. This evokes the possibility that NAPE possesses a biological function, as does NAE. We here examined if N-palmitoylphosphatidylethanolamine (NPPE), a precursor of N-palmitoylethanolamine, modulates the state of inflammation. We found that the level of the phagocytosis of latex beads, Staphylococcus aureus, Escherichia coli, or apoptotic cells by mouse peritoneal macrophages or J774A.1 macrophages was reduced in the presence of liposomes containing NPPE, while that of dextran remained unaffected. This action of NPPE seemed to be due to the inhibition of the activation of Rac1 and Cdc42 in macrophages. These results suggested that NAPE is bioactive lipid acting toward the termination of inflammation.
AuthorsAkiko Shiratsuchi, Manami Ichiki, Yasuo Okamoto, Natsuo Ueda, Naotoshi Sugimoto, Yoh Takuwa, Yoshinobu Nakanishi
JournalJournal of biochemistry (J Biochem) Vol. 145 Issue 1 Pg. 43-50 (Jan 2009) ISSN: 1756-2651 [Electronic] England
PMID18974159 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Liposomes
  • Lysophospholipids
  • 1-palmitoylphosphatidylethanolamine
  • cdc42 GTP-Binding Protein
  • rac1 GTP-Binding Protein
Topics
  • Animals
  • Cell Adhesion
  • Cells, Cultured
  • Female
  • Liposomes (chemistry)
  • Lysophospholipids (pharmacology)
  • Macrophages (drug effects, metabolism)
  • Mice
  • Mice, Inbred Strains
  • Phagocytosis
  • cdc42 GTP-Binding Protein (antagonists & inhibitors, metabolism)
  • rac1 GTP-Binding Protein (antagonists & inhibitors, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: